The Cancer

Don't Miss

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

Vital Information

Facts

Latest Articles

Actual-World Knowledge with Amtagvi Present Excessive Response Charges in Superior Melanoma

Iovance Biotherapeutics introduced information demonstrating that sufferers with superior melanoma skilled excessive response charges when handled with business Amtagvi (lifileucel) in a...

How Prevention and Entry Form Outcomes in Pores and skin Most cancers Care

Dr. Maral Kibarian Skelsey mentioned how advances in genetics and genomics are reshaping the understanding of pores and skin most cancers threat...

How Mantras Impacted My Life Throughout a Colon Most cancers Journey

Have you ever ever requested your self, “Why are mantras so impactful in somebody’s life?” or “What's the significance of getting your...

How Advances in Remedy Are Altering Pores and skin Most cancers Care

Dr. Jesse Miller Lewin sat down with CURE to debate how latest advances in systemic and native therapies are reshaping the therapy...

FDA Grants Orphan Drug Designation to Zenocutuzumab for Cholangiocarcinoma

The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to zenocutuzumab-zbco for the therapy of adults with superior unresectable...

Hot Topics